Single-port thoracoscopic sympathicotomy for treatment of raynaud's phenomenon, a feasibility study.

Single-port thoracoscopic sympathicotomy for treatment of raynaud's phenomenon, a feasibility study. - SPTS in Raynaud's

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46918

Enrollment

Registered

2018-03-16

Start date

2016-05-12

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Raynaud's disease

Interventions

Unilateral single-port sympathicotomy

Raynaud

Sympathicotomy

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 18-65 years of age Severe form of RP, defined as clinical need of prostacyclin analogue infusions having been given in the preceding 2 years, without satisfying result OR Severe form of RP, defined as clinical limiting in everyday life for the patient with presence of a contra-indication for prostacyclin, without satisfying result of standard care.

Exclusion criteria

Exclusion criteria: - Due to higher risk of complications following unilateral lung-deflation and re-insufflation: o Known COPD with evidence of emphysematous lung destruction on X-thorax or CT o History of smoking > 20 pack years o Lung involvement due to systemic autoimmune disease (based on previously described abnormalities on HRCT or documented pulmonary hypertension by mean pulmonary artery pressure 25 mmHg at rest measured by right heart catherisation). - Concurrent neurological disease

Design outcomes

Primary

Measure	Time frame
Cooling pletysmography Nailbed microscopy	—

Secondary

Measure	Time frame
Quality of life Comlaints diary	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)